Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $51M invested in Invesco Biotechnology & Genome ETF in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
14
Reduced
24
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
TAM
1
Trillium Asset Management
Boston,
Massachusetts
|
$1.02M |
2 |
2
LPL Financial
San Diego,
California
|
$2.38M |
3 |
VF
3
Virtu Financial
New York
|
$0 |
4 |
4
UBS Group
Zurich,
Switzerland
|
$4.09M |
5 |
5
Morgan Stanley
New York
|
$4.4M |